[HTML] mdpi.com

[HTML][HTML] Targeted therapy in advanced and metastatic non-small cell lung cancer. An update on treatment of the most important actionable oncogenic driver alterations

D Koenig, S Savic Prince, SI Rothschild - Cancers, 2021 - mdpi.com
Simple Summary The treatment of advanced and metastatic non-small cell lung cancer
(NSCLC) has changed dramatically in recent years due to advanced molecular diagnostics …
被引用次数：81 相关文章

Targeted Therapy in Advanced and Metastatic Non-Small Cell Lung Cancer. An Update on Treatment of the Most Important Actionable Oncogenic Driver Alterations …

D König, S Savic Prince, SI Rothschild - 2021 - search.proquest.com
Due to groundbreaking developments and continuous progress, the treatment of advanced
and metastatic non-small cell lung cancer (NSCLC) has become an exciting, but …
[PDF] semanticscholar.org

[PDF][PDF] Targeted Therapy in Advanced and Metastatic Non-Small Cell Lung Cancer. An Update on Treatment of the Most Important Actionable Oncogenic Driver …

D König, S Savic Prince, SI Rothschild - 2021 - pdfs.semanticscholar.org
Due to groundbreaking developments and continuous progress, the treatment of advanced
and metastatic non-small cell lung cancer (NSCLC) has become an exciting, but …

Targeted Therapy in Advanced and Metastatic Non-Small Cell Lung Cancer. An Update on Treatment of the Most Important Actionable Oncogenic Driver Alterations.

D König, SI Rothschild - Cancers, 2021 - europepmc.org
Due to groundbreaking developments and continuous progress, the treatment of advanced
and metastatic non-small cell lung cancer (NSCLC) has become an exciting, but …

Targeted Therapy in Advanced and Metastatic Non-Small Cell Lung Cancer. An Update on Treatment of the Most Important Actionable Oncogenic Driver Alterations

D König, SS Prince, SI Rothschild - Cancers, 2021 - pubmed.ncbi.nlm.nih.gov
Due to groundbreaking developments and continuous progress, the treatment of advanced
and metastatic non-small cell lung cancer (NSCLC) has become an exciting, but …
[PDF] academia.edu

[PDF][PDF] Targeted Therapy in Advanced and Metastatic Non-Small Cell Lung Cancer. An Update on Treatment of the Most Important Actionable Oncogenic Driver …

D König, S Savic Prince, SI Rothschild - 2021 - academia.edu
Due to groundbreaking developments and continuous progress, the treatment of advanced
and metastatic non-small cell lung cancer (NSCLC) has become an exciting, but …
[HTML] nih.gov

[HTML][HTML] Targeted Therapy in Advanced and Metastatic Non-Small Cell Lung Cancer. An Update on Treatment of the Most Important Actionable Oncogenic Driver …

D König, SS Prince, SI Rothschild - Cancers, 2021 - ncbi.nlm.nih.gov
Due to groundbreaking developments and continuous progress, the treatment of advanced
and metastatic non-small cell lung cancer (NSCLC) has become an exciting, but …

Targeted Therapy in Advanced and Metastatic Non-Small Cell Lung Cancer. An Update on Treatment of the Most Important Actionable Oncogenic Driver Alterations

D König, SS Prince, SI Rothschild - Cancers, 2021 - cir.nii.ac.jp
抄録< jats: p> Due to groundbreaking developments and continuous progress, the treatment
of advanced and metastatic non-small cell lung cancer (NSCLC) has become an exciting …

Targeted Therapy in Advanced and Metastatic Non-Small Cell Lung Cancer. An Update on Treatment of the Most Important Actionable Oncogenic Driver Alterations.

D König, S Savic Prince, SI Rothschild, R Alfieri - Cancers, 2021 - search.ebscohost.com
Abstract Simple Summary: The treatment of advanced and metastatic non-small cell lung
cancer (NSCLC) has changed dramatically in recent years due to advanced molecular …